IP Library Granted Patent US 6,989,262
Granted Patent B2
US 6,989,262 · App. 09/992,095 · Granted Jan 24, 2006

Plasmin variants and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,989,262
App. No.
09/992,095
Granted
Jan 24, 2006
Kind
B2
Abstract

The invention concerns plasmin variants. Polynucleotides the disclosed plasmin variants are provided. Additionally, methods of using the plasmin polynucleotides and polynucleotides are provided herein.

Claims (11)

1. A Plasminute polypeptide encoded by an isolated polynucleotide consisting of an open reading frame of the human cDNA of deposited clone 789749 — 182-14-3-0-C12-F.

2. An isolated Plasminute protease consisting of amino acids 1 to 207 of SEQ ID NO:54.

3. The protease of claim 2 , wherein said protease is a serine protease.

4. A composition comprising the protease of claim 2 and a physiologically acceptable carrier.

5. A composition comprising the polypeptide of claim 3 and a physiologically acceptable carrier.

6. A composition comprising the polypeptide of claim 1 and a physiologically acceptable carrier.

7. A method of digesting a protein consisting of contacting a protein with a) a Plasminute polypeptide encoded by an isolated polynucleotide comprising an open reading frame of the human cDNA of deposited clone 789749 — 182-14-3-0-C12-F; b) a Plasminute protease consisting of amino acids 1 to 207 of SEQ ID NO:54; or c) compositions thereof under conditions that allow for the digestion of said protein.

8. The method of claim 7 , wherein a protein is contacted with a Plasminute polypeptide encoded by an isolated polynucleotide consisting of an open reading frame of the human cDNA of deposited clone 789749 — 182-14-3-0-C12-F.

9. The method of claim 7 , wherein a protein is contacted with a Plasminute protease consisting of amino acids 1 to 207 of SEQ ID NO:54.

10. The method of claim 7 , wherein a protein is contacted with a composition comprising a carrier and a Plasminute protease consisting of amino acids 1 to 207 of SEQ ID NO:54.

11. The method of claim 7 , wherein a protein is contacted with a composition consisting of a carrier and a Plasminute polypeptide encoded by an isolated polynucleotide consisting of an open reading frame of the human cDNA of deposited clone 789749 — 182-14-3-0-C12-F.

Assignments (4)
CHANGE OF NAME Recorded Aug 3, 2005
From: GENSET S.A.
To: SERONO GENETICS INSTITUTE S.A.
Reel/Frame 016348/0865 →
CHANGE OF ASSIGNEE'S ADDRESS Recorded Nov 25, 2003
From: GENSET S.A.
To: GENSET S.A.
Reel/Frame 014158/0971 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 25, 2003
From: BEJANIN, STEPHANE; TANAKA, HIROAKI
To: GENSET, S.A.
Reel/Frame 014161/0605 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 1, 2002
From: BEJANIN, STEPHANE; TANAKA, HIROAKI
To: GENSET S.A.
Reel/Frame 012848/0874 →